ATE384129T1 - Künstliche antikörperbibliothek mit super- repertoire - Google Patents

Künstliche antikörperbibliothek mit super- repertoire

Info

Publication number
ATE384129T1
ATE384129T1 AT02803566T AT02803566T ATE384129T1 AT E384129 T1 ATE384129 T1 AT E384129T1 AT 02803566 T AT02803566 T AT 02803566T AT 02803566 T AT02803566 T AT 02803566T AT E384129 T1 ATE384129 T1 AT E384129T1
Authority
AT
Austria
Prior art keywords
library
region
repertoire
super
artificial antibodies
Prior art date
Application number
AT02803566T
Other languages
English (en)
Inventor
Nobuyoshi Shimizu
Atsushi Takayanagi
Michiyo Okui
Original Assignee
Univ Keio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Keio filed Critical Univ Keio
Application granted granted Critical
Publication of ATE384129T1 publication Critical patent/ATE384129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Applications Or Details Of Rotary Compressors (AREA)
AT02803566T 2001-11-22 2002-11-22 Künstliche antikörperbibliothek mit super- repertoire ATE384129T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001358602 2001-11-22

Publications (1)

Publication Number Publication Date
ATE384129T1 true ATE384129T1 (de) 2008-02-15

Family

ID=19169753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02803566T ATE384129T1 (de) 2001-11-22 2002-11-22 Künstliche antikörperbibliothek mit super- repertoire

Country Status (7)

Country Link
US (1) US8178320B2 (de)
EP (1) EP1457559B1 (de)
JP (1) JP4171844B2 (de)
AT (1) ATE384129T1 (de)
AU (1) AU2002366039A1 (de)
DE (1) DE60224720D1 (de)
WO (1) WO2003044198A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1670932B1 (de) * 2003-08-27 2011-03-30 Proterec Ltd Bibliotheken rekombinanter chimärischer proteine
JP4524414B2 (ja) * 2004-08-24 2010-08-18 学校法人東海大学 糖結合性ファージ提示型抗体の解析方法
JP2006055141A (ja) * 2004-08-24 2006-03-02 Tokai Univ 糖鎖構造に特異的な抗体の同定方法
JP2007306828A (ja) * 2006-05-17 2007-11-29 Tokai Univ 非還元マンノース残基を認識するファージ提示型単鎖抗体
JP5239766B2 (ja) 2008-11-14 2013-07-17 富士通セミコンダクター株式会社 レイアウト設計方法
US9029513B2 (en) 2010-06-04 2015-05-12 Toagosei Co. Ltd. Anti-EGFR antibody and use thereof
WO2014116051A1 (ko) 2013-01-24 2014-07-31 스크립스코리아 항체연구원 단백질 조합 기반의 Fv 라이브러리 및 이의 제조 방법
EP3246434A1 (de) * 2015-01-13 2017-11-22 Ewha University-Industry Collaboration Foundation Verfahren zur erstellung einer neuartigen antikörperbibliothek und damit erstellte bibliothek
EP3297661B1 (de) * 2015-05-21 2021-06-30 Full Spectrum Genetics, Inc. Verfahren zur verbesserung der eigenschaften von proteinen
BR112020003622A2 (pt) 2017-08-21 2020-09-01 Adagene Inc. cadeia pesada de anticorpo, anticorpo, bibliotecas, kit, método de preparo de uma biblioteca, método de produção de uma biblioteca de anticorpos, fago, método de geração de um anticorpo biespecífico e anticorpo biespecífico
WO2019036856A1 (en) 2017-08-21 2019-02-28 Adagene Inc. DYNAMIC BANKS OF LIGHT CHAIN OF HUMAN ANTIBODY
CN112557644B (zh) * 2020-12-21 2024-03-22 珠海碳云智能科技有限公司 用于对目标抗体进行检测的多肽的筛选方法及其筛选的多肽的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5855885A (en) * 1993-01-22 1999-01-05 Smith; Rodger Isolation and production of catalytic antibodies using phage technology
WO1995027045A1 (en) 1994-03-30 1995-10-12 Igen, Inc. The isolation and production of catalytic antibodies using phage technology
NZ500843A (en) 1995-06-07 2002-03-28 Invitrogen Corp A method of DNA recombination which is selectable to select for cells containing a product and against cells only harbouring the insert donor
DK0996718T3 (da) 1997-03-18 2009-04-06 Novozymes As Fremgangsmåde til konstruktion af et bibliotek ved anvendelse af DNA-shuffling
JP4206154B2 (ja) 1997-11-13 2009-01-07 大日本住友製薬株式会社 変異型ｌｏｘＰ配列とその応用
US6662113B1 (en) 1997-12-15 2003-12-09 Fujisawa Pharmaceutical Co., Ltd. Digital correlation of test samples and the screening of interactions between the same
IT1303776B1 (it) * 1998-11-19 2001-02-23 S I S S A Scuola Internaz Supe Processo per la preparazione di genoteche, di polipeptidi utilizzandodette genoteche e i polipepti ottenuti.
CA2373690A1 (en) * 1999-07-14 2001-01-25 Clontech Laboratories, Inc. Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
EP1092768A1 (de) * 1999-10-16 2001-04-18 ARTEMIS Pharmaceuticals GmbH Konstrukt zum bedingten einfangen und Disruption von Genen
GB0008419D0 (en) * 2000-04-05 2000-05-24 Bioinvent Int Ab A method for invitro molecular evolution of antibody function
AU2001271912A1 (en) 2000-07-07 2002-01-21 Maxygen, Inc. Molecular breeding of transposable elements
WO2002040685A2 (en) 2000-11-16 2002-05-23 Cornell Research Foundation, Inc. Vectors for conditional gene inactivation

Also Published As

Publication number Publication date
AU2002366039A1 (en) 2003-06-10
EP1457559A4 (de) 2005-10-12
EP1457559A1 (de) 2004-09-15
JP4171844B2 (ja) 2008-10-29
WO2003044198A1 (fr) 2003-05-30
EP1457559B1 (de) 2008-01-16
US20060057632A1 (en) 2006-03-16
US8178320B2 (en) 2012-05-15
JPWO2003044198A1 (ja) 2005-03-24
DE60224720D1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
DE60224720D1 (en) Re
IN2009KN02655A (de)
WO2004093808A3 (en) Novel tumor-associated antigens
EP1578799B8 (de) Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
WO2003068924A3 (en) Fusion proteins of humanized g250 specific antibodies and uses thereof
WO2003060080A3 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
CY1112843T1 (el) Μεθοδος παρασκευης υβριδικων αντισωματων
WO2002072605A3 (en) Expression technology for proteins containing a hybrid isotype antibody moiety
AU2001294541A1 (en) Mammalian genes; related reagents and methods
AU2001268855A1 (en) Single-domain antigen-binding antibody fragments derived from llama antibodies
WO2002062850A3 (en) Hybrid antibodies and uses thereof
CY1111097T1 (el) Πρωτεϊνη δεσμευσης του υποδοχεα nogo
WO2003057857A3 (en) Antibodies directed to pdgfd and uses thereof
ITRM20030601A1 (it) Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
ATE554107T1 (de) Als therapeutika geeignete monovalente antikörperfragmente
PT2308888T (pt) Anticorpos anti-il-6, composições, métodos e utilizações
WO2003092630A3 (en) Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
WO2004022717A3 (en) Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen
WO2005026210A3 (de) Therapeutic binding molecules
WO2002057794A3 (en) Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
AU2002359495A1 (en) Anti-tnf antibodies, compositions, methods and uses
WO2005023201A3 (en) Methods for treating rheumatoid arthritis
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
ATE512974T1 (de) Genetisch manipuliertes p30 antigen, verbesserter antigen-cocktail und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties